NCT01749462已完成不适用
Oxis 9mcg Turbuhaler Clinical Experience Investigation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 398
- 试验地点
- 1
- 主要终点
- Adverse event incidence
研究概览
简要总结
The purpose of the investigation is to confirm the ADR development and the contributing factors possibly having an impact on the safety under the post-marketing actual use of Oxis 9 mcg Turbuhaler.
详细描述
Oxis 9mcg Turbuhaler Clinical Experience Investigation
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients treated with Oxis for the first time due to 'relief of various symptoms associated with airway obstructive disorders of chronic obstructive pulmonary disease (Chronic bronchitis, Pulmonary emphysema), which is the indication of this drug.
排除标准
- 未提供
结局指标
主要结局
Adverse event incidence
时间窗: 12 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating EmergenceAnesthesiaNCT02820025General Hospital of Ningxia Medical University40
已完成
4 期
Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or NotBreast CancerNCT01553903Institut Claudius Regaud29
已完成
1 期
A Dose Titration of Droxidopa in Patients With Spinal Cord InjurySpinal Cord InjuryHypotensionNCT01354158Bronx VA Medical Center11
招募中
3 期
Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled TrialHepatocellular Carcinoma ResectableNCT05766605Zhujiang Hospital90
Unknown
不适用
Assessment of the Efficacy of Tracheal Oxygen Administration During Bronchoscopy - a Phase II TrialHypoxaemiaNCT01786642KU Leuven40